204 related articles for article (PubMed ID: 9990144)
1. A reevaluation of nystatin in prophylaxis and treatment of oropharyngeal candidiasis.
Alvarez Alvarez ME; Sánchez-Sousa A; Baquero F
Rev Esp Quimioter; 1998 Dec; 11(4):295-315. PubMed ID: 9990144
[TBL] [Abstract][Full Text] [Related]
2. Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patients.
Meunier F; Paesmans M; Autier P
Eur J Cancer B Oral Oncol; 1994 May; 30B(3):196-9. PubMed ID: 7920166
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Patton LL; Bonito AJ; Shugars DA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):170-9. PubMed ID: 11505264
[TBL] [Abstract][Full Text] [Related]
4. The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
Blignaut E; Botes ME; Nieman HL
SADJ; 1999 Dec; 54(12):605-8. PubMed ID: 16892568
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of nystatin in prevention and elimination of oropharyngeal Candida in immunosuppressed patients.
Barrett AP
Oral Surg Oral Med Oral Pathol; 1984 Aug; 58(2):148-51. PubMed ID: 6592508
[TBL] [Abstract][Full Text] [Related]
6. [Sensitivity of Candida strains to polyenic antibiotics in the treatment of oral candidiasis].
Boĭko GI; Sosnin GP; Adarchenko AA; Moroz GS
Antibiotiki; 1984 Nov; 29(11):869-72. PubMed ID: 6395795
[TBL] [Abstract][Full Text] [Related]
7. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
[TBL] [Abstract][Full Text] [Related]
8. Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
Redding SW; Bailey CW; Lopez-Ribot JL; Kirkpatrick WR; Fothergill AW; Rinaldi MG; Patterson TF
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):659-62. PubMed ID: 11402278
[TBL] [Abstract][Full Text] [Related]
9. Oral nystatin prophylaxis and neonatal fungal infections.
Howell A; Isaacs D; Halliday R;
Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F429-33. PubMed ID: 19321509
[TBL] [Abstract][Full Text] [Related]
10. Candidiasis: pathogenesis, clinical characteristics, and treatment.
Appleton SS
J Calif Dent Assoc; 2000 Dec; 28(12):942-8. PubMed ID: 11323949
[TBL] [Abstract][Full Text] [Related]
11. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
[TBL] [Abstract][Full Text] [Related]
12. [Phenomenon of increased resistance of yeast-like fungi to nystatin].
Nierebińska E; Gwieździński Z; Urbanowski S; Pracz M
Wiad Lek; 1992 Jun; 45(11-12):427-9. PubMed ID: 1441524
[TBL] [Abstract][Full Text] [Related]
13. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
[TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
Walmsley S; King S; McGeer A; Ye Y; Richardson S
Clin Infect Dis; 2001 Jun; 32(11):1554-61. PubMed ID: 11340526
[TBL] [Abstract][Full Text] [Related]
15. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis.
DeGregorio MW; Lee WM; Ries CA
Cancer; 1982 Dec; 50(12):2780-4. PubMed ID: 6958353
[TBL] [Abstract][Full Text] [Related]
16. Oropharyngeal candidiasis outcomes in renal transplant recipients receiving nystatin versus no antifungal prophylaxis.
Ky TQ; Park JM; McMurry KA; Tischer SM; Fitzgerald LJ; Cotiguala L
Transpl Infect Dis; 2021 Jun; 23(3):e13559. PubMed ID: 33387388
[TBL] [Abstract][Full Text] [Related]
17. A case of chronic oropharyngo-esophageal candidiasis with immunological deficiency: successful treatment with miconazole.
Tytgat GN; Surachno S; de Groot WP; Schellekens PT
Gastroenterology; 1977 Mar; 72(3):536-40. PubMed ID: 832803
[TBL] [Abstract][Full Text] [Related]
18. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
19. Antifungal prophylaxis for the prevention of neonatal candidiasis?
O'Grady MJ; Dempsey EM
Acta Paediatr; 2008 Apr; 97(4):430-3. PubMed ID: 18363952
[TBL] [Abstract][Full Text] [Related]
20. Oral and gastrointestinal candidosis: prophylaxis during immunosuppressive therapy.
Prentice AG
Mycoses; 1989; 32 Suppl 2():42-6. PubMed ID: 2700221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
